XML 32 R22.htm IDEA: XBRL DOCUMENT v3.22.1
Segment Information
3 Months Ended
Mar. 31, 2022
Segment Reporting [Abstract]  
Segment Information Segment Information
The following table summarizes select operating results for each reportable segment (in millions).
SuccessorPredecessor
Three Months Ended March 31, 2022Three Months Ended March 31, 2021
Revenues
Medical$60.1 $51.5 
Industrial103.1 114.7 
Consolidated Revenues$163.2 $166.2 
Segment (Loss) Income from Operations
Medical$(3.5)$(2.3)
Industrial(1.4)17.8 
Total Segment (Loss) Income from Operations(4.9)15.5 
Corporate and other(28.7)(24.4)
Consolidated Loss from Operations$(33.6)$(8.9)
The Company’s assets by reportable segment were not included, as this information is not reviewed by, nor otherwise provided to, the chief operating decision maker to make operating decisions or allocate resources.
The following details revenues by geographic region. Revenues generated from external customers are attributed to geographic regions through sales from site locations (i.e., point of origin) (in millions).
Revenues
SuccessorPredecessor
Three Months Ended March 31, 2022Three Months Ended March 31, 2021
North America
Medical$55.6 $47.2 
Industrial42.2 43.8 
Total North America97.8 91.0 
Europe
Medical4.5 4.3 
Industrial53.2 61.7 
Total Europe57.7 66.0 
Asia Pacific
Medical— — 
Industrial7.7 9.2 
Total Asia Pacific7.7 9.2 
Total revenues$163.2 $166.2 
The following details revenues by timing of recognition (in millions):
Revenues
SuccessorPredecessor
Three Months Ended March 31, 2022Three Months Ended March 31, 2021
Point in time$117.0 $121.4 
Over time46.2 44.8 
Total revenues$163.2 $166.2 
The following details revenues by product category (in millions):
Revenues
SuccessorPredecessor
Three Months Ended March 31, 2022Three Months Ended March 31, 2021
Medical segment:
Medical$60.1 $51.5 
Industrial segment:
Reactor Safety and Control Systems30.8 36.9 
Radiological Search, Measurement, and Analysis Systems72.3 77.8 
Total revenues$163.2 $166.2